Overview

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

The clinical trial will investigate the efficacy of Avanz Phleum pratense in the treatment of rhinitis in an environmental challenge chamber.

Phase:

Phase 2

Details

Lead Sponsor:

ALK-Abelló A/S